Illumina recently launched the MiSeq i100 and MiSeq i100 Plus Systems, two powerful, compact benchtop sequencers that incorporate more than 140 invention disclosures and 60 patent families. Through a ...

The Illumina MiSeq i100 Series, announced last fall, is the company's first customer-installable instrument since the iSeq. Illumina's latest offering was a brand-new challenge for Staff Software ...

Ravi, R.K., Walton, K. and Khosroheidari, M. (2018) MiSeq A Next Generation Sequencing Platform for Genomic Analysis. In DiStefano, J., Ed., Disease Gene ...

Illumina recently launched the MiSeq i100 and MiSeq i100 Plus Systems, two powerful, compact benchtop sequencers that incorporate more than 140 invention disclosures and 60 patent families. On our ...

Illumina recently launched the MiSeq i100 and MiSeq i100 Plus Systems, two powerful, compact benchtop sequencers that incorporate more than 140 invention disclosures and 60 patent families.

The MiSeq i100 Series brings Illumina's powerful XLEAP-SBS™ chemistry innovation even further—for the first time, harnessing the potential of room-temperature storage and shipping, which provides ...

San Diego’s Illumina unveils smaller, faster gene sequencer The San Diego company announced its latest MiSeq i100 benchtop sequencers on Wednesday ...

StockWatch: Investors Unfazed by Illumina’s MiSeq Product Launches, Starboard’s $1B Stake in Pfizer Shares of sequencing giant, pharma barely budge despite big news ...

Illumina has launched a new benchtop next-generation sequencing (NGS) system designed to be more accessible for use in smaller labs.